Related Experiment Video
Updated: Sep 25, 2025

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
Palliative sedation for children at end of life: a retrospective cohort study
Yang Chen1, Jianjun Jiang2, Wei Peng1
1Department of Palliative Medicine, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 18, Section 3, South Renmin Road, Wuhou District, Chengdu, Sichuan province, China.
Insights
Palliative sedation effectively manages complex symptoms in children at the end of life. This therapy improves symptom control without increasing hospitalization duration, offering crucial support during critical care.
Area of Science:
- Pediatric Palliative Care
- End-of-Life Symptom Management
- Sedative Therapy
Background:
- Palliative sedation involves intentionally reducing consciousness to relieve refractory symptoms.
- Research on palliative sedation specifically for children is limited.
- This study investigates symptom control and risks associated with sedative therapy in pediatric end-of-life care.
Purpose of the Study:
- To evaluate the effectiveness of palliative sedation in managing symptoms in children nearing end of life.
- To compare symptom relief, survival time, and hospitalization duration between sedated and non-sedated pediatric patients.
- To identify potential risks and benefits of palliative sedation in a pediatric palliative care setting.
Main Methods:
- A single-center, retrospective cohort study was conducted.
- Pediatric patients who died in the Palliative Medicine Department were divided into two groups: palliative sedation (Group A) and non-palliative sedation (Group B).
- Outcomes including symptom relief, survival time, and last hospitalization time were compared between the groups.
Main Results:
- A total of 41 children died during the study period; 24 received palliative sedation (Group A) and 17 did not (Group B).
- Group A experienced more complex symptoms (p=0.013) and demonstrated higher overall symptom relief (p=0.041) compared to Group B.
- While pain relief rates and opioid doses did not differ significantly, Group A had a longer survival time after diagnosis (p=0.047), with similar hospitalization lengths.
Conclusions:
- Palliative sedation is an effective method for controlling complex and painful symptoms in children at the end of life.
- Sedative therapy in pediatric palliative care does not appear to shorten hospitalization time.
- The findings support the use of palliative sedation for symptom management in pediatric end-of-life care.
Background:
Palliative sedation is consciously reducing the patient's consciousness to alleviate the refractory symptoms. However, studies on palliative sedation for children are scarce. We aimed to survey the symptom control and risks for children with sedative therapy in end of life.
Method:
This study was a single center retrospective cohort study. Children who died in the Department of Palliative Medicine were divided into palliative sedation (Group A) and non-palliative sedation group (Group B). The symptoms relief, survival time, and last hospitalization time were compared between two groups.
Results:
From January 2012 to November 2019, 41 children died in department of palliative care. 24 children were sedated (Group A), meanwhile 17 children were not (Group B). The symptoms in Group A were more complex than Group B (p = 0.013). Overall symptom relief in Group A was higher than that in Group B (24/24, 10/15 p = 0.041). Pain relief rates (7/7, 20/21 p = 0.714), maximum/pre-death opioid dose [30(20, 77.5), 18(9, 45) p = 0.175, 30(20, 60), 18(9, 45) p = 0.208] and pain intensity difference [5(4,6.5), 4(2,6) p = 0.315] did not differ significantly in either groups. After diagnosis, the survival time of the Group A was longer than the Group B (p = 0.047). However, the length of hospitalization before death was similar in two groups (p = 0.385).
Conclusion:
Palliative sedation controls complicated, painful symptoms at the end of life and does not shorten the hospitalization time in children.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Continuing Care
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Stages of General Anesthesia
Inhalational Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

